M C Sheppard|D B Ramsden - JoVE Visualize

Showing results (131-140 of 284) with videos related to

Pageof 29

Sort By:

Journal of the Neurological Sciences|May 1, 1995

Toxicity of sulphur-containing compounds to neuronal cell linesA R Pean, R B Parsons, R H Waring, et al.

Thyroid : Official Journal of the American Thyroid Association|October 1, 1995

Effect of estrogen replacement therapy upon bone mineral density in thyroxine-treated postmenopausal women with a past history of thyrotoxicosisJ A Franklyn, J Betteridge, R Holder, et al.

The Biochemical Journal|February 1, 1982

Characterization of immunoreactive somatostatin released from rat nervous system in vitroM C Sheppard, S Hendricks, A Hudson, et al.

Biochimica Et Biophysica Acta|September 3, 1979

Ultracentrifugation evidence for a somatostatin-binding protein in serumS Kronheim, M C Sheppard, B Shapiro, et al.

QJM : Monthly Journal of the Association of Physicians|March 1, 1995

Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidismJ A Franklyn, J Daykin, R Holder, et al.

Diabetologia|May 1, 1983

The effect of diet on intermediary metabolite concentrations in Type 2 (non-insulin-dependent) diabetes mellitusM C Sheppard, J Burrin, K G Alberti, et al.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1980

Tissue and serum somatostatin-like immunoreactivity in lean and obese Zucker ratsM C Sheppard, B Shapiro, A Hudson, et al.

Molecular Pathology : MP|March 14, 1998

Human cysteine dioxygenase type I (CDO-I; EC 1.13.11.20): 5' flanking region and intron-exon structure of the geneD B Ramsden, A Kapadi, N J Fitch, et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry|February 15, 1985

Conflict between classifications based on free thyroxine and thyroid stimulating hormone concentrations in thyroxine-treated patientsS Oldfield, D B Ramsden, K E Stephens, et al.

The Journal of Clinical Endocrinology and Metabolism|June 1, 1994

Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illnessJ A Franklyn, E G Black, J Betteridge, et al.

Pageof 29

Showing results (131-140 of 284) with videos related to

Sort By:

Pageof 29

Journal of the Neurological Sciences|May 1, 1995

Toxicity of sulphur-containing compounds to neuronal cell linesA R Pean, R B Parsons, R H Waring, et al.

Thyroid : Official Journal of the American Thyroid Association|October 1, 1995

Effect of estrogen replacement therapy upon bone mineral density in thyroxine-treated postmenopausal women with a past history of thyrotoxicosisJ A Franklyn, J Betteridge, R Holder, et al.

The Biochemical Journal|February 1, 1982

Characterization of immunoreactive somatostatin released from rat nervous system in vitroM C Sheppard, S Hendricks, A Hudson, et al.

Biochimica Et Biophysica Acta|September 3, 1979

Ultracentrifugation evidence for a somatostatin-binding protein in serumS Kronheim, M C Sheppard, B Shapiro, et al.

QJM : Monthly Journal of the Association of Physicians|March 1, 1995

Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidismJ A Franklyn, J Daykin, R Holder, et al.

Diabetologia|May 1, 1983

The effect of diet on intermediary metabolite concentrations in Type 2 (non-insulin-dependent) diabetes mellitusM C Sheppard, J Burrin, K G Alberti, et al.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1980

Tissue and serum somatostatin-like immunoreactivity in lean and obese Zucker ratsM C Sheppard, B Shapiro, A Hudson, et al.

Molecular Pathology : MP|March 14, 1998

Human cysteine dioxygenase type I (CDO-I; EC 1.13.11.20): 5' flanking region and intron-exon structure of the geneD B Ramsden, A Kapadi, N J Fitch, et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry|February 15, 1985

Conflict between classifications based on free thyroxine and thyroid stimulating hormone concentrations in thyroxine-treated patientsS Oldfield, D B Ramsden, K E Stephens, et al.

The Journal of Clinical Endocrinology and Metabolism|June 1, 1994

Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illnessJ A Franklyn, E G Black, J Betteridge, et al.

Pageof 29